Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB - Tsimihodimos,V.; Karabina,S.A.; Tambaki,A.P. (Arterioscler Thromb Vasc Biol, 2002)